Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tabilio

Showing results (111-120 of 139) with videos related to

Pageof 14
Sort By:
Cancer Research|October 1, 1983
Myeloid and megakaryocytic properties of K-562 cell linesA Tabilio, P G Pelicci, G Vinci, et al.
British Journal of Haematology|April 1, 1984
Immunological study of in vitro maturation of human megakaryocytesG Vinci, A Tabilio, J F Deschamps, et al.
Blood|May 26, 1999
Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cellsC Carlo-Stella, E Regazzi, G Sammarelli, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 26, 2001
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blastsP Lunghi, A Tabilio, S Pinelli, et al.
Blood|April 6, 2001
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplantsI Volpi, K Perruccio, A Tosti, et al.
Leukemia|March 28, 2008
MtDNA mutation associated with mitochondrial dysfunction in megakaryoblastic leukaemic cellsC Piccoli, M Ripoli, R Scrima, et al.
Tumori|August 16, 2001
Results of a prospective study with high-dose etoposide, thiotepa and carboplatin and peripheral blood stem cell rescue for high-risk stage II-IIIA and selected stage IV breast cancer patientsS Gori, A M Mosconi, A Tabilio, et al.
Haematologica|March 1, 1997
Allogeneic hematopoietic stem cells from sources other than bone marrow: biological and technical aspectsF Bertolini, A de Vincentiis, L Lanata, et al.
British Journal of Haematology|December 1, 1984
Expression of SSEA-I antigen (3-fucosyl-N-acetyl-lactosamine) on normal and leukaemic human haemopoietic cells: modulation by neuraminidase treatmentA Tabilio, M C Del Canizo, A Henri, et al.
Lancet (London, England)|February 22, 2005
Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trialM Bocchia, S Gentili, E Abruzzese, et al.
Pageof 14

Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
Cancer Research|October 1, 1983
Myeloid and megakaryocytic properties of K-562 cell linesA Tabilio, P G Pelicci, G Vinci, et al.
British Journal of Haematology|April 1, 1984
Immunological study of in vitro maturation of human megakaryocytesG Vinci, A Tabilio, J F Deschamps, et al.
Blood|May 26, 1999
Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cellsC Carlo-Stella, E Regazzi, G Sammarelli, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 26, 2001
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blastsP Lunghi, A Tabilio, S Pinelli, et al.
Blood|April 6, 2001
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplantsI Volpi, K Perruccio, A Tosti, et al.
Leukemia|March 28, 2008
MtDNA mutation associated with mitochondrial dysfunction in megakaryoblastic leukaemic cellsC Piccoli, M Ripoli, R Scrima, et al.
Tumori|August 16, 2001
Results of a prospective study with high-dose etoposide, thiotepa and carboplatin and peripheral blood stem cell rescue for high-risk stage II-IIIA and selected stage IV breast cancer patientsS Gori, A M Mosconi, A Tabilio, et al.
Haematologica|March 1, 1997
Allogeneic hematopoietic stem cells from sources other than bone marrow: biological and technical aspectsF Bertolini, A de Vincentiis, L Lanata, et al.
British Journal of Haematology|December 1, 1984
Expression of SSEA-I antigen (3-fucosyl-N-acetyl-lactosamine) on normal and leukaemic human haemopoietic cells: modulation by neuraminidase treatmentA Tabilio, M C Del Canizo, A Henri, et al.
Lancet (London, England)|February 22, 2005
Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trialM Bocchia, S Gentili, E Abruzzese, et al.
Pageof 14